Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
Open Access
- 9 May 2023
- journal article
- research article
- Published by Springer Nature in Scientific Data
- Vol. 10 (1) , 1-14
Abstract
Alzheimer’s disease (AD) is the most common form of dementia, with cerebrospinal fluid (CSF) β-amyloid (Aβ), total Tau, and phosphorylated Tau (pTau) providing the most sensitive and specific biomarkers for diagnosis. However, these diagnostic biomarkers do not reflect the complex changes in AD brain beyond amyloid (A) and Tau (T) pathologies. Here, we report a selected reaction monitoring mass spectrometry (SRM-MS) method with isotopically labeled standards for relative protein quantification in CSF. Biomarker positive (AT+) and negative (AT−) CSF pools were used as quality controls (QCs) to assess assay precision. We detected 62 peptides (51 proteins) with an average coefficient of variation (CV) of ~13% across 30 QCs and 133 controls (cognitively normal, AT−), 127 asymptomatic (cognitively normal, AT+) and 130 symptomatic AD (cognitively impaired, AT+). Proteins that could distinguish AT+ from AT− individuals included SMOC1, GDA, 14-3-3 proteins, and those involved in glycolysis. Proteins that could distinguish cognitive impairment were mainly neuronal proteins (VGF, NPTX2, NPTXR, and SCG2). This demonstrates the utility of SRM-MS to quantify CSF protein biomarkers across stages of AD.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG070937, P30AG066511, U01AG061357, U01AG061357, P30AG066511, R01AG070937)
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
This publication has 59 references indexed in Scilit:
- Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n = 669): A Pilot Assay for Methionine-containing Proteotypic PeptidesMolecular & Cellular Proteomics, 2012
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directionsNature Methods, 2012
- Effect of Collision Energy Optimization on the Measurement of Peptides by Selected Reaction Monitoring (SRM) Mass SpectrometryAnalytical Chemistry, 2010
- Progression of Cerebral Amyloid Load Is Associated with the Apolipoprotein E ε4 Genotype in Alzheimer's DiseaseBiological Psychiatry, 2010
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Classification and basic pathology of Alzheimer diseaseActa Neuropathologica, 2009
- Apolipoprotein E structure: insights into functionTrends in Biochemical Sciences, 2006
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's diseaseNeurology, 1993